デフォルト表紙
市場調査レポート
商品コード
1447179

ライフサイエンスIT市場:ソリューション別、タイプ別、エンドユーザー別:世界の機会分析と産業予測、2024年~2033年

Life Sciences IT Market By Solution, By Type, By End User : Global Opportunity Analysis and Industry Forecast, 2024-2033

出版日: | 発行: Allied Market Research | ページ情報: 英文 268 Pages | 納期: 2~3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.16円
ライフサイエンスIT市場:ソリューション別、タイプ別、エンドユーザー別:世界の機会分析と産業予測、2024年~2033年
出版日: 2024年01月30日
発行: Allied Market Research
ページ情報: 英文 268 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のライフサイエンスIT市場は、2023年に213億米ドルと評価され、2024年から2033年にかけてCAGR 11%で成長し、2033年には625億米ドルに達すると予測されています。

Life Sciences IT Market-IMG1

ライフサイエンスITは、製薬、バイオテクノロジー、ヘルスケアなどのライフサイエンス分野における情報技術の応用です。このITの専門分野は、研究開発から製造、患者のケアに至るまで、ライフサイエンス産業のさまざまな側面をサポートし、進歩させる上で極めて重要な役割を果たしています。ライフサイエンスITソフトウェアとサービスは、科学者や調査者が膨大な量の生物学的・化学的データを管理するのを助け、ライフサイエンス研究の様々な側面の分析を容易にします。この技術は創薬にとって極めて重要であり、潜在的な治療標的の特定や新薬開発の効率化に役立っています。

ライフサイエンスIT市場は、ライフサイエンス業界におけるライフサイエンス分析ソフトウェアの採用増加や、ラボの自動化動向の高まりにより、大きな成長が見込まれています。

ライフサイエンス分析ソフトウェアの採用増加は、ライフサイエンスIT市場の主要な促進要因として浮上しています。これは、高度な分析が研究開発プロセスの強化、業務効率の最適化、データ主導の意思決定の促進において果たす重要な役割に対する認識が高まっていることに起因しています。分析ソフトウェアは、ライフサイエンス企業がビッグデータや複雑なデータセットの力を活用することを可能にし、それによって研究者や科学者が膨大な情報から意味のある洞察を引き出せるようにします。

高度な分析ツールの統合により、創薬・開発プロセスが大幅に合理化され、より正確な標的同定、生物学的経路のより深い理解、臨床試験デザインの加速が可能になった。例えば、国立医学図書館による2020年の報告書によると、ビッグデータは、臨床研究や生物学的データに牽引されるその他の研究分野で認知されつつあります。さらに、分析ソフトウェアは、リアルタイムのモニタリングと報告を容易にするため、規制遵守を確保する上で重要な役割を果たしており、それによって研究データの全体的な品質と完全性が向上しています。

さらに、研究室の自動化に向けた動向の高まりは、ライフサイエンスIT市場の成長の主要促進要因として作用すると予想されます。ライフサイエンスITソリューションは、ライフサイエンス研究者や専門家が直面する独自の課題に対処するために設計されており、研究室のワークフローの様々な側面を統合し最適化する包括的なプラットフォームを提供します。ラボラトリーオートメーションソフトウェアの主な利点の一つはデータ管理にあり、これらのソフトウェアシステムは、膨大で複雑な科学データのシームレスな整理、保存、検索を容易にします。これはデータの正確性を高めるだけでなく、手作業によるミスを減らし、管理作業に費やす時間を減らすことで、研究のペースを加速させる。

さらに、ライフサイエンスITソリューションは、サンプルの追跡や実験の実施からデータ分析に至るまで、研究室のプロセスの自動化に大きく貢献しています。例えば、ライフサイエンス・ソリューションの世界的企業であるサーモフィッシャーサイエンティフィック社は、ラボ自動化のためのワークフロースケジューリングソフトウェアMomentumを提供しています。このソフトウェアは、強力で使いやすいビジュアル環境で、科学的プロセスやワークフローを定義、実行、監視することができます。その直感的なスケジューリング・インターフェース、インテリジェントなデータ駆動型の意思決定機能、優れた接続性、柔軟なシミュレーション・モードは、優れたパフォーマンスを達成するのに役立ちます。

自動化は作業を迅速化するだけでなく、実験の一貫性と再現性を保証します。このように、研究室の自動化へ向けた動向の高まりは、市場の成長に大きく貢献すると予想されます。

しかし、データ・セキュリティとプライバシーに関する懸念が、市場の成長を抑制する主要な懸念として浮上しています。ライフサイエンス業界は、患者記録、臨床試験情報、ゲノムデータなど、機密性の高い膨大なデータの収集、保管、分析に大きく依存しています。ヘルスケア・プロセスのデジタル化が進み、クラウド・コンピューティングやビッグデータ分析などの先端技術が採用されるにつれ、データ漏洩や不正アクセスのリスクは高まっています。そのため、データ・セキュリティやプライバシーに関する懸念が市場の成長を抑制すると予想されます。

ライフサイエンスIT市場は、ソリューション、タイプ、エンドユーザー、地域によって区分されます。ソリューション別では、創薬インフォマティクス、臨床試験管理、バイオインフォマティクス、ラボ情報管理、その他に分けられます。タイプ別では、ソフトウェアとサービスに二分されます。エンドユーザー別では、製薬・バイオテクノロジー企業、研究開発受託機関、その他に区分されます。地域別では、北米(米国、カナダ、メキシコ)、欧州(ドイツ、フランス、英国、イタリア、スペイン、その他欧州地域)、アジア太平洋地域(中国、日本、オーストラリア、インド、韓国、その他アジア太平洋地域)、アジア太平洋地域(ブラジル、日本、アラビア、オーストラリア、インド、韓国、その他アジア太平洋地域)で分析されています。

利害関係者にとっての主なメリット

  • 当レポートでは、2023年から2033年にかけてのライフサイエンスit市場分析の市場セグメント、現在の動向、推定・動向分析、ダイナミクスを定量的に分析し、一般的なライフサイエンスit市場の機会を特定します。
  • 市場促進要因、市場抑制要因、市場機会に関連する情報とともに市場調査を提供します。
  • ポーターのファイブフォース分析では、利害関係者が利益重視のビジネス決定を下し、サプライヤーとバイヤーのネットワークを強化できるよう、バイヤーとサプライヤーの潜在力を明らかにします。
  • ライフサイエンス市場セグメンテーションの詳細分析により、市場機会を見極めることができます。
  • 各地域の主要国は、世界市場への収益貢献度に応じてマッピングされています。
  • 市場プレイヤーのポジショニングはベンチマーキングを容易にし、市場プレイヤーの現在のポジションを明確に理解することができます。
  • 本レポートには、地域別および世界のライフサイエンス市場動向、主要企業、市場セグメント、応用分野、市場成長戦略の分析が含まれています。

本レポートはカスタマイズが可能です。

  • 規制ガイドライン
  • 顧客の関心に応じた企業プロファイルの追加
  • 国別または地域別の追加分析-市場規模と予測
  • 企業プロファイルの拡張リスト
  • 過去の市場データ
  • 主要企業の詳細(所在地、連絡先、サプライヤー/ベンダーネットワークなどを含む、エクセル形式)

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場概要

  • 市場の定義と範囲
  • 主な調査結果
    • 影響要因
    • 主な投資機会
  • ポーターのファイブフォース分析
  • 市場力学
    • 促進要因
      • ラボ自動化への動向の高まり。
      • 高度な分析ツールに対する需要の高まり
      • 創薬プロセスにおけるライフサイエンスITソリューションの高い採用率。
    • 抑制要因
      • データのプライバシーとセキュリティに関する懸念
    • 機会
      • ライフサイエンスIT技術の技術的進歩

第4章 ライフサイエンスIT市場:ソリューション別

  • 概要
  • 創薬インフォマティクス
  • 臨床試験管理
  • バイオインフォマティクス
  • 臨床検査情報管理
  • その他

第5章 ライフサイエンスIT市場:タイプ別

  • 概要
  • ソフトウェア
  • サービス

第6章 ライフサイエンスIT市場:エンドユーザー別

  • 概要
  • 製薬・バイオテクノロジー企業
  • 研究開発受託機関
  • その他

第7章 ライフサイエンスIT市場:地域別

  • 概要
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • その他
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • オーストラリア
    • 韓国
    • その他
  • ラテンアメリカ・中東・アフリカ
    • ブラジル
    • サウジアラビア
    • 南アフリカ
    • その他

第8章 競争情勢

  • イントロダクション
  • 主要成功戦略
  • 主要10社の製品マッピング
  • 競合ダッシュボード
  • 競合ヒートマップ
  • 主要企業のポジショニング、2023年

第9章 企業プロファイル

  • Thermo Fisher Scientific Inc.
  • Qiagen NV.
  • Agilent Technologies, Inc.
  • Oracle Corporation
  • Revvity, Inc.
  • Clario
  • IBM Corporation
  • DNAnexus, Inc.
  • Genedata AG
  • Illumina, Inc.
図表

LIST OF TABLES

  • TABLE 01. GLOBAL LIFE SCIENCES IT MARKET, BY SOLUTION, 2023-2033 ($MILLION)
  • TABLE 02. LIFE SCIENCES IT MARKET FOR DRUG DISCOVERY INFORMATICS, BY REGION, 2023-2033 ($MILLION)
  • TABLE 03. LIFE SCIENCES IT MARKET FOR CLINICAL TRIAL MANAGEMENT, BY REGION, 2023-2033 ($MILLION)
  • TABLE 04. LIFE SCIENCES IT MARKET FOR BIOINFORMATICS, BY REGION, 2023-2033 ($MILLION)
  • TABLE 05. LIFE SCIENCES IT MARKET FOR LABORATORY INFORMATION MANAGEMENT, BY REGION, 2023-2033 ($MILLION)
  • TABLE 06. LIFE SCIENCES IT MARKET FOR OTHERS, BY REGION, 2023-2033 ($MILLION)
  • TABLE 07. GLOBAL LIFE SCIENCES IT MARKET, BY TYPE, 2023-2033 ($MILLION)
  • TABLE 08. LIFE SCIENCES IT MARKET FOR SOFTWARE, BY REGION, 2023-2033 ($MILLION)
  • TABLE 09. LIFE SCIENCES IT MARKET FOR SERVICE, BY REGION, 2023-2033 ($MILLION)
  • TABLE 10. GLOBAL LIFE SCIENCES IT MARKET, BY END USER, 2023-2033 ($MILLION)
  • TABLE 11. LIFE SCIENCES IT MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2023-2033 ($MILLION)
  • TABLE 12. LIFE SCIENCES IT MARKET FOR CONTRACT RESEARCH AND DEVELOPMENT ORGANIZATIONS, BY REGION, 2023-2033 ($MILLION)
  • TABLE 13. LIFE SCIENCES IT MARKET FOR OTHERS, BY REGION, 2023-2033 ($MILLION)
  • TABLE 14. LIFE SCIENCES IT MARKET, BY REGION, 2023-2033 ($MILLION)
  • TABLE 15. NORTH AMERICA LIFE SCIENCES IT MARKET, BY SOLUTION, 2023-2033 ($MILLION)
  • TABLE 16. NORTH AMERICA LIFE SCIENCES IT MARKET, BY TYPE, 2023-2033 ($MILLION)
  • TABLE 17. NORTH AMERICA LIFE SCIENCES IT MARKET, BY END USER, 2023-2033 ($MILLION)
  • TABLE 18. NORTH AMERICA LIFE SCIENCES IT MARKET, BY COUNTRY, 2023-2033 ($MILLION)
  • TABLE 19. U.S. LIFE SCIENCES IT MARKET, BY SOLUTION, 2023-2033 ($MILLION)
  • TABLE 20. U.S. LIFE SCIENCES IT MARKET, BY TYPE, 2023-2033 ($MILLION)
  • TABLE 21. U.S. LIFE SCIENCES IT MARKET, BY END USER, 2023-2033 ($MILLION)
  • TABLE 22. CANADA LIFE SCIENCES IT MARKET, BY SOLUTION, 2023-2033 ($MILLION)
  • TABLE 23. CANADA LIFE SCIENCES IT MARKET, BY TYPE, 2023-2033 ($MILLION)
  • TABLE 24. CANADA LIFE SCIENCES IT MARKET, BY END USER, 2023-2033 ($MILLION)
  • TABLE 25. MEXICO LIFE SCIENCES IT MARKET, BY SOLUTION, 2023-2033 ($MILLION)
  • TABLE 26. MEXICO LIFE SCIENCES IT MARKET, BY TYPE, 2023-2033 ($MILLION)
  • TABLE 27. MEXICO LIFE SCIENCES IT MARKET, BY END USER, 2023-2033 ($MILLION)
  • TABLE 28. EUROPE LIFE SCIENCES IT MARKET, BY SOLUTION, 2023-2033 ($MILLION)
  • TABLE 29. EUROPE LIFE SCIENCES IT MARKET, BY TYPE, 2023-2033 ($MILLION)
  • TABLE 30. EUROPE LIFE SCIENCES IT MARKET, BY END USER, 2023-2033 ($MILLION)
  • TABLE 31. EUROPE LIFE SCIENCES IT MARKET, BY COUNTRY, 2023-2033 ($MILLION)
  • TABLE 32. GERMANY LIFE SCIENCES IT MARKET, BY SOLUTION, 2023-2033 ($MILLION)
  • TABLE 33. GERMANY LIFE SCIENCES IT MARKET, BY TYPE, 2023-2033 ($MILLION)
  • TABLE 34. GERMANY LIFE SCIENCES IT MARKET, BY END USER, 2023-2033 ($MILLION)
  • TABLE 35. FRANCE LIFE SCIENCES IT MARKET, BY SOLUTION, 2023-2033 ($MILLION)
  • TABLE 36. FRANCE LIFE SCIENCES IT MARKET, BY TYPE, 2023-2033 ($MILLION)
  • TABLE 37. FRANCE LIFE SCIENCES IT MARKET, BY END USER, 2023-2033 ($MILLION)
  • TABLE 38. UK LIFE SCIENCES IT MARKET, BY SOLUTION, 2023-2033 ($MILLION)
  • TABLE 39. UK LIFE SCIENCES IT MARKET, BY TYPE, 2023-2033 ($MILLION)
  • TABLE 40. UK LIFE SCIENCES IT MARKET, BY END USER, 2023-2033 ($MILLION)
  • TABLE 41. ITALY LIFE SCIENCES IT MARKET, BY SOLUTION, 2023-2033 ($MILLION)
  • TABLE 42. ITALY LIFE SCIENCES IT MARKET, BY TYPE, 2023-2033 ($MILLION)
  • TABLE 43. ITALY LIFE SCIENCES IT MARKET, BY END USER, 2023-2033 ($MILLION)
  • TABLE 44. SPAIN LIFE SCIENCES IT MARKET, BY SOLUTION, 2023-2033 ($MILLION)
  • TABLE 45. SPAIN LIFE SCIENCES IT MARKET, BY TYPE, 2023-2033 ($MILLION)
  • TABLE 46. SPAIN LIFE SCIENCES IT MARKET, BY END USER, 2023-2033 ($MILLION)
  • TABLE 47. REST OF EUROPE LIFE SCIENCES IT MARKET, BY SOLUTION, 2023-2033 ($MILLION)
  • TABLE 48. REST OF EUROPE LIFE SCIENCES IT MARKET, BY TYPE, 2023-2033 ($MILLION)
  • TABLE 49. REST OF EUROPE LIFE SCIENCES IT MARKET, BY END USER, 2023-2033 ($MILLION)
  • TABLE 50. ASIA-PACIFIC LIFE SCIENCES IT MARKET, BY SOLUTION, 2023-2033 ($MILLION)
  • TABLE 51. ASIA-PACIFIC LIFE SCIENCES IT MARKET, BY TYPE, 2023-2033 ($MILLION)
  • TABLE 52. ASIA-PACIFIC LIFE SCIENCES IT MARKET, BY END USER, 2023-2033 ($MILLION)
  • TABLE 53. ASIA-PACIFIC LIFE SCIENCES IT MARKET, BY COUNTRY, 2023-2033 ($MILLION)
  • TABLE 54. JAPAN LIFE SCIENCES IT MARKET, BY SOLUTION, 2023-2033 ($MILLION)
  • TABLE 55. JAPAN LIFE SCIENCES IT MARKET, BY TYPE, 2023-2033 ($MILLION)
  • TABLE 56. JAPAN LIFE SCIENCES IT MARKET, BY END USER, 2023-2033 ($MILLION)
  • TABLE 57. CHINA LIFE SCIENCES IT MARKET, BY SOLUTION, 2023-2033 ($MILLION)
  • TABLE 58. CHINA LIFE SCIENCES IT MARKET, BY TYPE, 2023-2033 ($MILLION)
  • TABLE 59. CHINA LIFE SCIENCES IT MARKET, BY END USER, 2023-2033 ($MILLION)
  • TABLE 60. INDIA LIFE SCIENCES IT MARKET, BY SOLUTION, 2023-2033 ($MILLION)
  • TABLE 61. INDIA LIFE SCIENCES IT MARKET, BY TYPE, 2023-2033 ($MILLION)
  • TABLE 62. INDIA LIFE SCIENCES IT MARKET, BY END USER, 2023-2033 ($MILLION)
  • TABLE 63. AUSTRALIA LIFE SCIENCES IT MARKET, BY SOLUTION, 2023-2033 ($MILLION)
  • TABLE 64. AUSTRALIA LIFE SCIENCES IT MARKET, BY TYPE, 2023-2033 ($MILLION)
  • TABLE 65. AUSTRALIA LIFE SCIENCES IT MARKET, BY END USER, 2023-2033 ($MILLION)
  • TABLE 66. SOUTH KOREA LIFE SCIENCES IT MARKET, BY SOLUTION, 2023-2033 ($MILLION)
  • TABLE 67. SOUTH KOREA LIFE SCIENCES IT MARKET, BY TYPE, 2023-2033 ($MILLION)
  • TABLE 68. SOUTH KOREA LIFE SCIENCES IT MARKET, BY END USER, 2023-2033 ($MILLION)
  • TABLE 69. REST OF ASIA-PACIFIC LIFE SCIENCES IT MARKET, BY SOLUTION, 2023-2033 ($MILLION)
  • TABLE 70. REST OF ASIA-PACIFIC LIFE SCIENCES IT MARKET, BY TYPE, 2023-2033 ($MILLION)
  • TABLE 71. REST OF ASIA-PACIFIC LIFE SCIENCES IT MARKET, BY END USER, 2023-2033 ($MILLION)
  • TABLE 72. LAMEA LIFE SCIENCES IT MARKET, BY SOLUTION, 2023-2033 ($MILLION)
  • TABLE 73. LAMEA LIFE SCIENCES IT MARKET, BY TYPE, 2023-2033 ($MILLION)
  • TABLE 74. LAMEA LIFE SCIENCES IT MARKET, BY END USER, 2023-2033 ($MILLION)
  • TABLE 75. LAMEA LIFE SCIENCES IT MARKET, BY COUNTRY, 2023-2033 ($MILLION)
  • TABLE 76. BRAZIL LIFE SCIENCES IT MARKET, BY SOLUTION, 2023-2033 ($MILLION)
  • TABLE 77. BRAZIL LIFE SCIENCES IT MARKET, BY TYPE, 2023-2033 ($MILLION)
  • TABLE 78. BRAZIL LIFE SCIENCES IT MARKET, BY END USER, 2023-2033 ($MILLION)
  • TABLE 79. SAUDI ARABIA LIFE SCIENCES IT MARKET, BY SOLUTION, 2023-2033 ($MILLION)
  • TABLE 80. SAUDI ARABIA LIFE SCIENCES IT MARKET, BY TYPE, 2023-2033 ($MILLION)
  • TABLE 81. SAUDI ARABIA LIFE SCIENCES IT MARKET, BY END USER, 2023-2033 ($MILLION)
  • TABLE 82. SOUTH AFRICA LIFE SCIENCES IT MARKET, BY SOLUTION, 2023-2033 ($MILLION)
  • TABLE 83. SOUTH AFRICA LIFE SCIENCES IT MARKET, BY TYPE, 2023-2033 ($MILLION)
  • TABLE 84. SOUTH AFRICA LIFE SCIENCES IT MARKET, BY END USER, 2023-2033 ($MILLION)
  • TABLE 85. REST OF LAMEA LIFE SCIENCES IT MARKET, BY SOLUTION, 2023-2033 ($MILLION)
  • TABLE 86. REST OF LAMEA LIFE SCIENCES IT MARKET, BY TYPE, 2023-2033 ($MILLION)
  • TABLE 87. REST OF LAMEA LIFE SCIENCES IT MARKET, BY END USER, 2023-2033 ($MILLION)
  • TABLE 88. THERMO FISHER SCIENTIFIC INC. : KEY EXECUTIVES
  • TABLE 89. THERMO FISHER SCIENTIFIC INC. : COMPANY SNAPSHOT
  • TABLE 90. THERMO FISHER SCIENTIFIC INC. : PRODUCT SEGMENTS
  • TABLE 91. THERMO FISHER SCIENTIFIC INC. : SERVICE SEGMENTS
  • TABLE 92. THERMO FISHER SCIENTIFIC INC. : PRODUCT PORTFOLIO
  • TABLE 93. QIAGEN NV.: KEY EXECUTIVES
  • TABLE 94. QIAGEN NV.: COMPANY SNAPSHOT
  • TABLE 95. QIAGEN NV.: PRODUCT SEGMENTS
  • TABLE 96. QIAGEN NV.: PRODUCT PORTFOLIO
  • TABLE 97. QIAGEN NV.: KEY STRATERGIES
  • TABLE 98. AGILENT TECHNOLOGIES, INC.: KEY EXECUTIVES
  • TABLE 99. AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT
  • TABLE 100. AGILENT TECHNOLOGIES, INC.: PRODUCT SEGMENTS
  • TABLE 101. AGILENT TECHNOLOGIES, INC.: PRODUCT PORTFOLIO
  • TABLE 102. ORACLE CORPORATION: KEY EXECUTIVES
  • TABLE 103. ORACLE CORPORATION: COMPANY SNAPSHOT
  • TABLE 104. ORACLE CORPORATION: SERVICE SEGMENTS
  • TABLE 105. ORACLE CORPORATION: PRODUCT PORTFOLIO
  • TABLE 106. REVVITY, INC.: KEY EXECUTIVES
  • TABLE 107. REVVITY, INC.: COMPANY SNAPSHOT
  • TABLE 108. REVVITY, INC.: PRODUCT SEGMENTS
  • TABLE 109. REVVITY, INC.: PRODUCT PORTFOLIO
  • TABLE 110. REVVITY, INC.: KEY STRATERGIES
  • TABLE 111. CLARIO: KEY EXECUTIVES
  • TABLE 112. CLARIO: COMPANY SNAPSHOT
  • TABLE 113. CLARIO: PRODUCT SEGMENTS
  • TABLE 114. CLARIO: PRODUCT PORTFOLIO
  • TABLE 115. CLARIO: KEY STRATERGIES
  • TABLE 116. IBM CORPORATION: KEY EXECUTIVES
  • TABLE 117. IBM CORPORATION: COMPANY SNAPSHOT
  • TABLE 118. IBM CORPORATION: PRODUCT SEGMENTS
  • TABLE 119. IBM CORPORATION: PRODUCT PORTFOLIO
  • TABLE 120. DNANEXUS, INC.: KEY EXECUTIVES
  • TABLE 121. DNANEXUS, INC.: COMPANY SNAPSHOT
  • TABLE 122. DNANEXUS, INC.: PRODUCT SEGMENTS
  • TABLE 123. DNANEXUS, INC.: PRODUCT PORTFOLIO
  • TABLE 124. DNANEXUS, INC.: KEY STRATERGIES
  • TABLE 125. GENEDATA AG: KEY EXECUTIVES
  • TABLE 126. GENEDATA AG: COMPANY SNAPSHOT
  • TABLE 127. GENEDATA AG: PRODUCT SEGMENTS
  • TABLE 128. GENEDATA AG: PRODUCT PORTFOLIO
  • TABLE 129. GENEDATA AG: KEY STRATERGIES
  • TABLE 130. ILLUMINA, INC.: KEY EXECUTIVES
  • TABLE 131. ILLUMINA, INC.: COMPANY SNAPSHOT
  • TABLE 132. ILLUMINA, INC.: PRODUCT SEGMENTS
  • TABLE 133. ILLUMINA, INC.: PRODUCT PORTFOLIO

LIST OF FIGURES

  • FIGURE 01. LIFE SCIENCES IT MARKET, 2023-2033
  • FIGURE 02. SEGMENTATION OF LIFE SCIENCES IT MARKET,2023-2033
  • FIGURE 03. TOP IMPACTING FACTORS IN LIFE SCIENCES IT MARKET (2023 TO 2024)
  • FIGURE 04. TOP INVESTMENT POCKETS IN LIFE SCIENCES IT MARKET (2024-2033)
  • FIGURE 05. LOW BARGAINING POWER OF SUPPLIERS
  • FIGURE 06. LOW THREAT OF NEW ENTRANTS
  • FIGURE 07. LOW THREAT OF SUBSTITUTES
  • FIGURE 08. LOW INTENSITY OF RIVALRY
  • FIGURE 09. LOW BARGAINING POWER OF BUYERS
  • FIGURE 10. GLOBAL LIFE SCIENCES IT MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
  • FIGURE 11. LIFE SCIENCES IT MARKET, BY SOLUTION, 2023 AND 2033(%)
  • FIGURE 12. COMPARATIVE SHARE ANALYSIS OF LIFE SCIENCES IT MARKET FOR DRUG DISCOVERY INFORMATICS, BY COUNTRY 2023 AND 2033(%)
  • FIGURE 13. COMPARATIVE SHARE ANALYSIS OF LIFE SCIENCES IT MARKET FOR CLINICAL TRIAL MANAGEMENT, BY COUNTRY 2023 AND 2033(%)
  • FIGURE 14. COMPARATIVE SHARE ANALYSIS OF LIFE SCIENCES IT MARKET FOR BIOINFORMATICS, BY COUNTRY 2023 AND 2033(%)
  • FIGURE 15. COMPARATIVE SHARE ANALYSIS OF LIFE SCIENCES IT MARKET FOR LABORATORY INFORMATION MANAGEMENT, BY COUNTRY 2023 AND 2033(%)
  • FIGURE 16. COMPARATIVE SHARE ANALYSIS OF LIFE SCIENCES IT MARKET FOR OTHERS, BY COUNTRY 2023 AND 2033(%)
  • FIGURE 17. LIFE SCIENCES IT MARKET, BY TYPE, 2023 AND 2033(%)
  • FIGURE 18. COMPARATIVE SHARE ANALYSIS OF LIFE SCIENCES IT MARKET FOR SOFTWARE, BY COUNTRY 2023 AND 2033(%)
  • FIGURE 19. COMPARATIVE SHARE ANALYSIS OF LIFE SCIENCES IT MARKET FOR SERVICE, BY COUNTRY 2023 AND 2033(%)
  • FIGURE 20. LIFE SCIENCES IT MARKET, BY END USER, 2023 AND 2033(%)
  • FIGURE 21. COMPARATIVE SHARE ANALYSIS OF LIFE SCIENCES IT MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY 2023 AND 2033(%)
  • FIGURE 22. COMPARATIVE SHARE ANALYSIS OF LIFE SCIENCES IT MARKET FOR CONTRACT RESEARCH AND DEVELOPMENT ORGANIZATIONS, BY COUNTRY 2023 AND 2033(%)
  • FIGURE 23. COMPARATIVE SHARE ANALYSIS OF LIFE SCIENCES IT MARKET FOR OTHERS, BY COUNTRY 2023 AND 2033(%)
  • FIGURE 24. LIFE SCIENCES IT MARKET BY REGION, 2023 AND 2033(%)
  • FIGURE 25. U.S. LIFE SCIENCES IT MARKET, 2023-2033 ($MILLION)
  • FIGURE 26. CANADA LIFE SCIENCES IT MARKET, 2023-2033 ($MILLION)
  • FIGURE 27. MEXICO LIFE SCIENCES IT MARKET, 2023-2033 ($MILLION)
  • FIGURE 28. GERMANY LIFE SCIENCES IT MARKET, 2023-2033 ($MILLION)
  • FIGURE 29. FRANCE LIFE SCIENCES IT MARKET, 2023-2033 ($MILLION)
  • FIGURE 30. UK LIFE SCIENCES IT MARKET, 2023-2033 ($MILLION)
  • FIGURE 31. ITALY LIFE SCIENCES IT MARKET, 2023-2033 ($MILLION)
  • FIGURE 32. SPAIN LIFE SCIENCES IT MARKET, 2023-2033 ($MILLION)
  • FIGURE 33. REST OF EUROPE LIFE SCIENCES IT MARKET, 2023-2033 ($MILLION)
  • FIGURE 34. JAPAN LIFE SCIENCES IT MARKET, 2023-2033 ($MILLION)
  • FIGURE 35. CHINA LIFE SCIENCES IT MARKET, 2023-2033 ($MILLION)
  • FIGURE 36. INDIA LIFE SCIENCES IT MARKET, 2023-2033 ($MILLION)
  • FIGURE 37. AUSTRALIA LIFE SCIENCES IT MARKET, 2023-2033 ($MILLION)
  • FIGURE 38. SOUTH KOREA LIFE SCIENCES IT MARKET, 2023-2033 ($MILLION)
  • FIGURE 39. REST OF ASIA-PACIFIC LIFE SCIENCES IT MARKET, 2023-2033 ($MILLION)
  • FIGURE 40. BRAZIL LIFE SCIENCES IT MARKET, 2023-2033 ($MILLION)
  • FIGURE 41. SAUDI ARABIA LIFE SCIENCES IT MARKET, 2023-2033 ($MILLION)
  • FIGURE 42. SOUTH AFRICA LIFE SCIENCES IT MARKET, 2023-2033 ($MILLION)
  • FIGURE 43. REST OF LAMEA LIFE SCIENCES IT MARKET, 2023-2033 ($MILLION)
  • FIGURE 44. TOP WINNING STRATEGIES, BY YEAR (2021-2024)
  • FIGURE 45. TOP WINNING STRATEGIES, BY DEVELOPMENT (2021-2024)
  • FIGURE 46. TOP WINNING STRATEGIES, BY COMPANY (2021-2024)
  • FIGURE 47. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 48. COMPETITIVE DASHBOARD
  • FIGURE 49. COMPETITIVE HEATMAP: LIFE SCIENCES IT MARKET
  • FIGURE 50. TOP PLAYER POSITIONING, 2023
  • FIGURE 51. THERMO FISHER SCIENTIFIC INC. : NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 52. THERMO FISHER SCIENTIFIC INC. : REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 53. THERMO FISHER SCIENTIFIC INC. : REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 54. QIAGEN NV.: NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 55. QIAGEN NV.: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 56. QIAGEN NV.: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 57. AGILENT TECHNOLOGIES, INC.: NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 58. AGILENT TECHNOLOGIES, INC.: RESEARCH & DEVELOPMENT EXPENDITURE, 2020-2022 ($MILLION)
  • FIGURE 59. AGILENT TECHNOLOGIES, INC.: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 60. AGILENT TECHNOLOGIES, INC.: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 61. ORACLE CORPORATION: NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 62. ORACLE CORPORATION: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 63. ORACLE CORPORATION: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 64. IBM CORPORATION: NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 65. IBM CORPORATION: RESEARCH & DEVELOPMENT EXPENDITURE, 2020-2022 ($MILLION)
  • FIGURE 66. IBM CORPORATION: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 67. IBM CORPORATION: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 68. ILLUMINA, INC.: NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 69. ILLUMINA, INC.: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 70. ILLUMINA, INC.: REVENUE SHARE BY REGION, 2022 (%)
目次
Product Code: A310277

The global life sciences IT market was valued at $21.3 billion in 2023, and is projected to reach $62.5 billion by 2033, growing at a CAGR of 11% from 2024 to 2033.

Life Sciences IT Market - IMG1

Life science IT is the application of information technology in the field of life sciences, including pharmaceuticals, biotechnology, and healthcare. This specialized branch of IT plays a pivotal role in supporting and advancing various aspects of the life sciences industry, from R&D to manufacturing and patient care. Life science IT software and services aid scientists and researchers in managing vast amounts of biological and chemical data, facilitating the analysis of various aspects of life sciences research. This technology is crucial for drug discovery, helping to streamline the identification of potential therapeutic targets and the development of new drugs.

The life science IT market is expected to register significant growth, owing to rise in adoption of life sciences analytical software in life sciences industry, and growing trend towards laboratory automation.

Rise in adoption of the life sciences analytical software has emerged as major driver for the life science IT market. This can be attributed to increasing awareness about the crucial role that advanced analytics plays in enhancing R&D processes, optimizing operational efficiency, and facilitating data-driven decision-making. Analytical software enables life sciences companies to harness the power of big data and complex datasets; thereby empowering researchers and scientists to extract meaningful insights from vast pools of information.

The integration of sophisticated analytics tools has significantly streamlined drug discovery and development processes, allowing for more precise target identification, better understanding of biological pathways, and accelerated clinical trial designs. For instance, according to a 2020 report by National Library of Medicine, big data is gaining recognition in clinical studies and other research areas driven by biological data. Moreover, analytical software plays a crucial role in ensuring regulatory compliance, as it facilitates real-time monitoring and reporting; thereby enhancing the overall quality and integrity of research data.

Furthermore, the growing trend towards the laboratory automation is expected to act as a major driver for the growth of the life science IT market. Life science IT solutions are designed to address the unique challenges faced by life sciences researchers and professionals, offering a comprehensive platform that integrates and optimizes various facets of laboratory workflows. One of the key advantages of laboratory automation software lies in data management, where these software systems facilitate seamless organization, storage, and retrieval of vast volumes of complex scientific data. This not only enhances data accuracy but also accelerates the pace of research by reducing manual errors and the time spent on administrative tasks.

Furthermore, life science IT solutions contribute significantly to the automation of laboratory processes, ranging from sample tracking and experiment execution to data analysis. For instance, Thermo Fisher Scientific Inc., a global life science solution company provides Momentum workflow scheduling software for laboratory automation. It enables users to define, execute, and monitor scientific processes and workflows in a powerful yet easy-to-use visual environment. Its intuitive scheduling interface, intelligent data-driven decision-making capabilities, superior connectivity, and flexible simulation modes help attain superior performance.

Automation not only expedites tasks but also ensures consistency and reproducibility in experiments, which is a crucial factor in maintaining high-quality research standards. Thus, the growing trend towards laboratory automation is expected to contribute significantly in the growth of the market.

However, data security and privacy concerns have emerged as major concerns restraining the growth of the market. The life sciences industry relies heavily on the collection, storage, and analysis of vast amounts of sensitive and confidential data, including patient records, clinical trial information, and genomic data. With increase in digitization of healthcare processes and the adoption of advanced technologies such as cloud computing and big data analytics, the risk of data breaches and unauthorized access has escalated. Thus, data security and privacy concerns are expected to restrain the growth of the market.

The life science IT market is segmented on the basis of solution, type, end user, and region. By solution, it is divided into drug discovery informatics, clinical trial management, bioinformatics, laboratory information management, and others. By type, it is bifurcated into software and services. By end user, it is segmented into pharmaceutical and biotechnology companies, contract R&D organizations, and other. Region-wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

The major players profiled in the report are Thermo Fisher Scientific Inc, Illumina, Qiagen N.V., Revvity, Inc, Agilent Technologies Inc, Oracle, Clario Inc, IBM Corp, DNAnexus Inc, and Genedata AG.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the life sciences it market analysis from 2023 to 2033 to identify the prevailing life sciences it market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the life sciences it market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global life sciences it market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data
  • Key player details (including location, contact details, supplier/vendor network etc. in excel format)

Key Market Segments

By Solution

  • Drug Discovery Informatics
  • Clinical Trial Management
  • Bioinformatics
  • Laboratory Information Management
  • Others

By Type

  • Software
  • Service

By End User

  • Others
  • Pharmaceutical and Biotechnology Companies
  • Contract Research and Development Organizations

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players:

    • Thermo Fisher Scientific Inc.
    • Qiagen NV.
    • Agilent Technologies, Inc.
    • Oracle Corporation
    • Clario
    • IBM Corporation
    • Genedata AG
    • Illumina, Inc.
    • Revvity, Inc.
    • DNAnexus, Inc.

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report description
  • 1.2. Key market segments
  • 1.3. Key benefits to the stakeholders
  • 1.4. Research methodology
    • 1.4.1. Primary research
    • 1.4.2. Secondary research
    • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Key findings
    • 3.2.1. Top impacting factors
    • 3.2.2. Top investment pockets
  • 3.3. Porter's five forces analysis
    • 3.3.1. Low bargaining power of suppliers
    • 3.3.2. Low threat of new entrants
    • 3.3.3. Low threat of substitutes
    • 3.3.4. Low intensity of rivalry
    • 3.3.5. Low bargaining power of buyers
  • 3.4. Market dynamics
    • 3.4.1. Drivers
      • 3.4.1.1. Growing trend towards laboratory automation.
      • 3.4.1.2. Rise in demand for advance analytical tool
      • 3.4.1.3. High adoption of life sciences IT solutions in drug discovery process.
    • 3.4.2. Restraints
      • 3.4.2.1. Data privacy and security concerns
    • 3.4.3. Opportunities
      • 3.4.3.1. Technological advancement in life sciences IT technology

CHAPTER 4: LIFE SCIENCES IT MARKET, BY SOLUTION

  • 4.1. Overview
    • 4.1.1. Market size and forecast
  • 4.2. Drug Discovery Informatics
    • 4.2.1. Key market trends, growth factors and opportunities
    • 4.2.2. Market size and forecast, by region
    • 4.2.3. Market share analysis by country
  • 4.3. Clinical Trial Management
    • 4.3.1. Key market trends, growth factors and opportunities
    • 4.3.2. Market size and forecast, by region
    • 4.3.3. Market share analysis by country
  • 4.4. Bioinformatics
    • 4.4.1. Key market trends, growth factors and opportunities
    • 4.4.2. Market size and forecast, by region
    • 4.4.3. Market share analysis by country
  • 4.5. Laboratory Information Management
    • 4.5.1. Key market trends, growth factors and opportunities
    • 4.5.2. Market size and forecast, by region
    • 4.5.3. Market share analysis by country
  • 4.6. Others
    • 4.6.1. Key market trends, growth factors and opportunities
    • 4.6.2. Market size and forecast, by region
    • 4.6.3. Market share analysis by country

CHAPTER 5: LIFE SCIENCES IT MARKET, BY TYPE

  • 5.1. Overview
    • 5.1.1. Market size and forecast
  • 5.2. Software
    • 5.2.1. Key market trends, growth factors and opportunities
    • 5.2.2. Market size and forecast, by region
    • 5.2.3. Market share analysis by country
  • 5.3. Service
    • 5.3.1. Key market trends, growth factors and opportunities
    • 5.3.2. Market size and forecast, by region
    • 5.3.3. Market share analysis by country

CHAPTER 6: LIFE SCIENCES IT MARKET, BY END USER

  • 6.1. Overview
    • 6.1.1. Market size and forecast
  • 6.2. Pharmaceutical and Biotechnology Companies
    • 6.2.1. Key market trends, growth factors and opportunities
    • 6.2.2. Market size and forecast, by region
    • 6.2.3. Market share analysis by country
  • 6.3. Contract Research and Development Organizations
    • 6.3.1. Key market trends, growth factors and opportunities
    • 6.3.2. Market size and forecast, by region
    • 6.3.3. Market share analysis by country
  • 6.4. Others
    • 6.4.1. Key market trends, growth factors and opportunities
    • 6.4.2. Market size and forecast, by region
    • 6.4.3. Market share analysis by country

CHAPTER 7: LIFE SCIENCES IT MARKET, BY REGION

  • 7.1. Overview
    • 7.1.1. Market size and forecast By Region
  • 7.2. North America
    • 7.2.1. Key market trends, growth factors and opportunities
    • 7.2.2. Market size and forecast, by Solution
    • 7.2.3. Market size and forecast, by Type
    • 7.2.4. Market size and forecast, by End User
    • 7.2.5. Market size and forecast, by country
      • 7.2.5.1. U.S.
      • 7.2.5.1.1. Market size and forecast, by Solution
      • 7.2.5.1.2. Market size and forecast, by Type
      • 7.2.5.1.3. Market size and forecast, by End User
      • 7.2.5.2. Canada
      • 7.2.5.2.1. Market size and forecast, by Solution
      • 7.2.5.2.2. Market size and forecast, by Type
      • 7.2.5.2.3. Market size and forecast, by End User
      • 7.2.5.3. Mexico
      • 7.2.5.3.1. Market size and forecast, by Solution
      • 7.2.5.3.2. Market size and forecast, by Type
      • 7.2.5.3.3. Market size and forecast, by End User
  • 7.3. Europe
    • 7.3.1. Key market trends, growth factors and opportunities
    • 7.3.2. Market size and forecast, by Solution
    • 7.3.3. Market size and forecast, by Type
    • 7.3.4. Market size and forecast, by End User
    • 7.3.5. Market size and forecast, by country
      • 7.3.5.1. Germany
      • 7.3.5.1.1. Market size and forecast, by Solution
      • 7.3.5.1.2. Market size and forecast, by Type
      • 7.3.5.1.3. Market size and forecast, by End User
      • 7.3.5.2. France
      • 7.3.5.2.1. Market size and forecast, by Solution
      • 7.3.5.2.2. Market size and forecast, by Type
      • 7.3.5.2.3. Market size and forecast, by End User
      • 7.3.5.3. UK
      • 7.3.5.3.1. Market size and forecast, by Solution
      • 7.3.5.3.2. Market size and forecast, by Type
      • 7.3.5.3.3. Market size and forecast, by End User
      • 7.3.5.4. Italy
      • 7.3.5.4.1. Market size and forecast, by Solution
      • 7.3.5.4.2. Market size and forecast, by Type
      • 7.3.5.4.3. Market size and forecast, by End User
      • 7.3.5.5. Spain
      • 7.3.5.5.1. Market size and forecast, by Solution
      • 7.3.5.5.2. Market size and forecast, by Type
      • 7.3.5.5.3. Market size and forecast, by End User
      • 7.3.5.6. Rest of Europe
      • 7.3.5.6.1. Market size and forecast, by Solution
      • 7.3.5.6.2. Market size and forecast, by Type
      • 7.3.5.6.3. Market size and forecast, by End User
  • 7.4. Asia-Pacific
    • 7.4.1. Key market trends, growth factors and opportunities
    • 7.4.2. Market size and forecast, by Solution
    • 7.4.3. Market size and forecast, by Type
    • 7.4.4. Market size and forecast, by End User
    • 7.4.5. Market size and forecast, by country
      • 7.4.5.1. Japan
      • 7.4.5.1.1. Market size and forecast, by Solution
      • 7.4.5.1.2. Market size and forecast, by Type
      • 7.4.5.1.3. Market size and forecast, by End User
      • 7.4.5.2. China
      • 7.4.5.2.1. Market size and forecast, by Solution
      • 7.4.5.2.2. Market size and forecast, by Type
      • 7.4.5.2.3. Market size and forecast, by End User
      • 7.4.5.3. India
      • 7.4.5.3.1. Market size and forecast, by Solution
      • 7.4.5.3.2. Market size and forecast, by Type
      • 7.4.5.3.3. Market size and forecast, by End User
      • 7.4.5.4. Australia
      • 7.4.5.4.1. Market size and forecast, by Solution
      • 7.4.5.4.2. Market size and forecast, by Type
      • 7.4.5.4.3. Market size and forecast, by End User
      • 7.4.5.5. South Korea
      • 7.4.5.5.1. Market size and forecast, by Solution
      • 7.4.5.5.2. Market size and forecast, by Type
      • 7.4.5.5.3. Market size and forecast, by End User
      • 7.4.5.6. Rest of Asia-Pacific
      • 7.4.5.6.1. Market size and forecast, by Solution
      • 7.4.5.6.2. Market size and forecast, by Type
      • 7.4.5.6.3. Market size and forecast, by End User
  • 7.5. LAMEA
    • 7.5.1. Key market trends, growth factors and opportunities
    • 7.5.2. Market size and forecast, by Solution
    • 7.5.3. Market size and forecast, by Type
    • 7.5.4. Market size and forecast, by End User
    • 7.5.5. Market size and forecast, by country
      • 7.5.5.1. Brazil
      • 7.5.5.1.1. Market size and forecast, by Solution
      • 7.5.5.1.2. Market size and forecast, by Type
      • 7.5.5.1.3. Market size and forecast, by End User
      • 7.5.5.2. Saudi Arabia
      • 7.5.5.2.1. Market size and forecast, by Solution
      • 7.5.5.2.2. Market size and forecast, by Type
      • 7.5.5.2.3. Market size and forecast, by End User
      • 7.5.5.3. South Africa
      • 7.5.5.3.1. Market size and forecast, by Solution
      • 7.5.5.3.2. Market size and forecast, by Type
      • 7.5.5.3.3. Market size and forecast, by End User
      • 7.5.5.4. Rest of LAMEA
      • 7.5.5.4.1. Market size and forecast, by Solution
      • 7.5.5.4.2. Market size and forecast, by Type
      • 7.5.5.4.3. Market size and forecast, by End User

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top winning strategies
  • 8.3. Product mapping of top 10 player
  • 8.4. Competitive dashboard
  • 8.5. Competitive heatmap
  • 8.6. Top player positioning, 2023

CHAPTER 9: COMPANY PROFILES

  • 9.1. Thermo Fisher Scientific Inc.
    • 9.1.1. Company overview
    • 9.1.2. Key executives
    • 9.1.3. Company snapshot
    • 9.1.4. Operating business segments
    • 9.1.5. Product portfolio
    • 9.1.6. Business performance
  • 9.2. Qiagen NV.
    • 9.2.1. Company overview
    • 9.2.2. Key executives
    • 9.2.3. Company snapshot
    • 9.2.4. Operating business segments
    • 9.2.5. Product portfolio
    • 9.2.6. Business performance
    • 9.2.7. Key strategic moves and developments
  • 9.3. Agilent Technologies, Inc.
    • 9.3.1. Company overview
    • 9.3.2. Key executives
    • 9.3.3. Company snapshot
    • 9.3.4. Operating business segments
    • 9.3.5. Product portfolio
    • 9.3.6. Business performance
  • 9.4. Oracle Corporation
    • 9.4.1. Company overview
    • 9.4.2. Key executives
    • 9.4.3. Company snapshot
    • 9.4.4. Operating business segments
    • 9.4.5. Product portfolio
    • 9.4.6. Business performance
  • 9.5. Revvity, Inc.
    • 9.5.1. Company overview
    • 9.5.2. Key executives
    • 9.5.3. Company snapshot
    • 9.5.4. Operating business segments
    • 9.5.5. Product portfolio
    • 9.5.6. Key strategic moves and developments
  • 9.6. Clario
    • 9.6.1. Company overview
    • 9.6.2. Key executives
    • 9.6.3. Company snapshot
    • 9.6.4. Operating business segments
    • 9.6.5. Product portfolio
    • 9.6.6. Key strategic moves and developments
  • 9.7. IBM Corporation
    • 9.7.1. Company overview
    • 9.7.2. Key executives
    • 9.7.3. Company snapshot
    • 9.7.4. Operating business segments
    • 9.7.5. Product portfolio
    • 9.7.6. Business performance
  • 9.8. DNAnexus, Inc.
    • 9.8.1. Company overview
    • 9.8.2. Key executives
    • 9.8.3. Company snapshot
    • 9.8.4. Operating business segments
    • 9.8.5. Product portfolio
    • 9.8.6. Key strategic moves and developments
  • 9.9. Genedata AG
    • 9.9.1. Company overview
    • 9.9.2. Key executives
    • 9.9.3. Company snapshot
    • 9.9.4. Operating business segments
    • 9.9.5. Product portfolio
    • 9.9.6. Key strategic moves and developments
  • 9.10. Illumina, Inc.
    • 9.10.1. Company overview
    • 9.10.2. Key executives
    • 9.10.3. Company snapshot
    • 9.10.4. Operating business segments
    • 9.10.5. Product portfolio
    • 9.10.6. Business performance